INDV Indivior Plc

1,409.00

-13.00 (-0.91%)

Last Updated: 11:01:30

Delayed by 15 minutes

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Indivior Plc	LSE:INDV	London	Ordinary Share	GB00BN4HT335	ORD USD0.50

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	-13.00	-0.91%	1,409.00	1,407.00	1,412.00	1,433.00	1,407.00	1,427.00	13,559	11:01:30

Industry Sector	Turnover	Profit	EPS - Basic	PE Ratio	Market Cap
Pharmaceutical Preparations	1.09B	2M	0.0148	955.41	1.91B

Indivior PLC Director Declaration (3081B)

19/09/2018 3:35pm

UK Regulatory

Indivior (LSE:INDV)
Historical Stock Chart

From May 2019 to May 2024

TIDMINDV

RNS Number : 3081B

Indivior PLC

19 September 2018

Indivior PLC (the 'Company')

Indivior PLC confirms that Mr Howard Pien, Non-Executive Chairman, was appointed as an independent director of Idera Pharmaceuticals, Inc., a specialty pharmaceutical company listed on the NASDAQ Stock Market, with effect from September 18, 2018.

This announcement is made in accordance with Listing Rule 9.6.14.

Kathryn Hudson

Company Secretary

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

RDNFKCDNQBKDPCD

(END) Dow Jones Newswires

September 19, 2018 10:35 ET (14:35 GMT)